Dr Jauhar graduated in Medicine from Glasgow University in 2002, having also completed a degree in Public Health and Epidemiology. His research interests focus on understanding neurobiological causes of psychotic illness, with a focus on the affective psychoses, and treatment of psychotic and affective illnesses. He also has a keen interest in evidence-based medicine and treatments, both pharmacological and non-pharmacological in affective and psychotic illness. He received a Royal College of Physicians, Edinburgh JMAS Sim Fellowship in 2018, enabling him to build on work examining the presynaptic dopamine system in affective psychoses. Clinically, he has worked as a Consultant Psychiatrist in Early Intervention in Psychosis since 2012, throughout South London and Maudsley NHS Trust.
Sameer Jauhar summarises a recent narrative review about the risk of schizophrenia linked to the Spanish Influenza Pandemic over 100 years ago. He relates this work to our current pandemic and considers the possibility of a link between COVID-19 and an increased risk of psychosis.
Sameer Jauhar and colleagues critically assess the evidence for Open Dialogue, presented in a recent narrative review of quantitative and qualitative studies, which finds that most current studies are highly biased and of low quality, and there is an absence of clear data on effectiveness.
Joseph Hayes and Sameer Jauhar set the record straight on antidepressant withdrawal. They show how the recent review by Davies and Read is seriously flawed and does not accurately portray the data. They conclude that we urgently need clearer evidence on the incidence, severity and duration of any symptoms related to antidepressant withdrawal.
Sameer Jauhar and Paul Morrison consider the revised Understanding Psychosis and Schizophrenia report from the British Psychological Society Division of Clinical Psychology, which includes updated sections on definitions, aetiology and treatment.
The relationship between cannabis and psychosis has been one of the hottest topics in psychiatry over the last decade, and with good reason. Policy-makers still disagree on whether cannabis should be legalised or how it should be classified, with Uruguay being the most recent country to legalise it. Drawing broadly from work initiated by Robin [read the full story…]
